On ECHEMI
Home > Drugs > Zhuhai Tongyuan Pharmaceutical Co., Ltd.

Zhuhai Tongyuan Pharmaceutical Co., Ltd.

  • Founded in:

    1990-05-11
  • Country:

    China China
  • Address:

    No. 6, Jinhai East Road, Sanzao, Jinwan District, Zhuhai City
  • Tax NO.:

    91440400192522224J
  • Registered Funds:

    50 million yuan
  • Website:

  • Email:

Related Drugs
Yanhuning for injection
Yan Hu Ning.
Name Description Content CAS NO. Registered Holders
PotassiuM sodiuM Dehydroandrographolide Succinate

This product is made from the extract of Rhizoma Atractylodis Macrocephalae through esterification, dehydration and salt formation. It can inhibit the early increase of capillary permeability, inflammatory exudation and edema, specifically stimulate the pituitary-adrenal cortex function, promote ACTH release, and increase the biosynthesis of ACTH in the anterior pituitary; it has the effect of inactivating adenovirus, influenza virus, respiratory virus and other viruses in vitro. Animal experiments have shown anti-early and mid-pregnancy effects.

More

This product is made from the extract of Rhizoma Atractylodis Macrocephalae through esterification, dehydration and salt formation. It can inhibit the early increase of capillary permeability, inflammatory exudation and edema, specifically stimulate the pituitary-adrenal cortex function, promote ACTH release, and increase the biosynthesis of ACTH in the anterior pituitary; it has the effect of inactivating adenovirus, influenza virus, respiratory virus and other viruses in vitro. Animal experiments have shown anti-early and mid-pregnancy effects.

863319-40-8 43
Compound Glycyrrhizic Acid Monoammonium S for Injection
This product is a compound preparation, its components are: glycyrrhizic acid, cysteine hydrochloride, and glycine.
Name Description Content CAS NO. Registered Holders
Glycyrrhizic acid

Anti-inflammatory effects: (1) Anti-allergic effects: It can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman Phenomenon and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymus atrophy effects. (2) Inhibitory effect on arachidonic acid metabolic enzymes: It can directly bind to phospholipase A2, the starting enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

More

Anti-inflammatory effects: (1) Anti-allergic effects: It can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman Phenomenon and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymus atrophy effects. (2) Inhibitory effect on arachidonic acid metabolic enzymes: It can directly bind to phospholipase A2, the starting enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

1405-86-3 1
L-Cysteine monohydrochloride

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

More

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

52-89-1 11
Glycine

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

More

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

56-40-6 27
Alanyl-Glutamine for Injection
The main ingredient of this product and its chemical name is N (2) -L-alanyl-L-glutamine.
Name Description Content CAS NO. Registered Holders
N-(2)-L-alanyl-L-glutamine

It can be decomposed into glutamine and alanine in the body, and glutamine can be supplemented through parenteral nutrition infusion. The amino acids released by the decomposition of dipeptides are stored in the corresponding parts of the body as nutrients and metabolized according to the needs of the body. This product can be used for parenteral nutrition support for diseases that may cause glutamine depletion in the body.

More

It can be decomposed into glutamine and alanine in the body, and glutamine can be supplemented through parenteral nutrition infusion. The amino acids released by the decomposition of dipeptides are stored in the corresponding parts of the body as nutrients and metabolized according to the needs of the body. This product can be used for parenteral nutrition support for diseases that may cause glutamine depletion in the body.

0
Alanyl-Glutamine for Injection
The main ingredient of this product and its chemical name is N (2) -L-alanyl-L-glutamine.
Name Description Content CAS NO. Registered Holders
N-(2)-L-alanyl-L-glutamine

It can be broken down into glutamine and alanine in the body, which are stored in the corresponding parts of the body as nutrients and metabolized according to the needs of the body. This product can be used for parenteral nutrition support for diseases that may cause glutamine depletion in the body.

More

It can be broken down into glutamine and alanine in the body, which are stored in the corresponding parts of the body as nutrients and metabolized according to the needs of the body. This product can be used for parenteral nutrition support for diseases that may cause glutamine depletion in the body.

0
N-(2)-L-alanyl-L-glutamine

It can be broken down into glutamine and alanine in the body, which are stored in the corresponding parts of the body as nutrients and metabolized according to the needs of the body. This product can be used for parenteral nutrition support for diseases that may cause glutamine depletion in the body.

More

It can be broken down into glutamine and alanine in the body, which are stored in the corresponding parts of the body as nutrients and metabolized according to the needs of the body. This product can be used for parenteral nutrition support for diseases that may cause glutamine depletion in the body.

0
Ambroxol Hydrochloride Dispersible Tablets
trans-4-[(2-amino-3,5-dibromophenyl)methyl-amino]-cyclohexanol hydrochloride
Name Description Content CAS NO. Registered Holders
trans-4-[(2-amino-3,5-dibromophenyl)methyl-amino]-cyclohexanol hydrochloride

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, increasing bronchial ciliary movement, and making sputum easier to cough up.

More

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, increasing bronchial ciliary movement, and making sputum easier to cough up.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.